Lantern Pharma reported net income of -$7.08M for the quarter ended Jun 2026. This income statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 11.19M | 11.09M | 10.83M | 10.83M | 10.86M | 10.86M | 10.86M | 10.87M | 10.87M | 10.72M | 10.76M | 10.76M | 10.78M | 10.78M | 10.78M | 10.78M | 11.04M | 11.25M | 11.25M | 12.76M | ||||||||
| Operating items | ||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 2.96M | 2.16M | 2.66M | 2.99M | 0.70M | 2.25M | 2.55M | 3.56M | 2.21M | 3.57M | 4.25M | 3.89M | 3.72M | 4.27M | 3.26M | 3.07M | 2.44M | 2.74M | 1.72M | 1.79M | ||||||||
| Selling, General & AdministrativeSG&A | 1.18M | 1.35M | 1.41M | 1.41M | 1.44M | 1.57M | 1.73M | 1.63M | 1.31M | 1.30M | 1.48M | 1.52M | 1.46M | 1.63M | 1.51M | 1.58M | 1.91M | 1.46M | 1.68M | 1.72M | ||||||||
| Restructuring CostsRestructuring | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M | 0.04M | 0.04M | |||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.04M | -0.04M | -0.04M | -0.04M | -0.03M | -0.04M | -0.04M | |||||||||||||||||||||
| Operating ExpensesOpex | 4.15M | 3.51M | 4.07M | 4.39M | 2.15M | 3.83M | 4.29M | 5.19M | 3.52M | 4.88M | 5.73M | 5.41M | 5.18M | 5.90M | 4.77M | 4.65M | 4.35M | 4.20M | 3.41M | 3.51M | ||||||||
| Operating IncomeOp. Inc | -4.15M | -3.51M | -4.07M | -4.39M | -2.15M | -3.83M | -4.29M | -5.19M | -3.52M | -4.88M | -5.73M | -5.41M | -5.18M | -5.90M | -4.77M | -4.65M | -4.35M | -4.20M | -3.41M | -3.51M | ||||||||
| EBIT | -4.15M | -3.51M | -4.07M | -4.39M | -2.15M | -3.83M | -4.29M | -5.19M | -3.52M | -4.88M | -5.73M | -5.41M | -5.18M | -5.90M | -4.77M | -4.65M | -4.35M | -4.20M | -3.41M | -3.51M | ||||||||
| Non-operating items | ||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.08M | -0.22M | -0.21M | -0.06M | -0.12M | 0.10M | 0.13M | 0.12M | 0.25M | 0.27M | 0.20M | 0.19M | 0.19M | 0.16M | 0.15M | 0.11M | 0.10M | 0.07M | 0.04M | 0.03M | ||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.02M | 0.03M | -0.08M | -0.15M | -0.17M | 0.37M | 0.28M | 0.33M | 0.12M | 0.42M | 0.09M | 0.26M | 0.48M | -0.14M | 0.09M | 0.21M | 0.07M | 0.06M | 0.03M | 0.01M | ||||||||
| Net income details | ||||||||||||||||||||||||||||
| EBT | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Profit After TaxPAT | -4.11M | -3.53M | -4.12M | -4.49M | -2.35M | -3.32M | -3.87M | -4.75M | -3.16M | -4.19M | -5.44M | -4.96M | -4.52M | -5.88M | -4.54M | -4.41M | -4.19M | -4.09M | -3.33M | -7.08M | ||||||||
| Income from Non-Controlling InterestsInc. Minority | 4.05M | 3.54M | 4.12M | |||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Consolidated Net IncomeConsol Net Inc. | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Income towards Parent CompanyParent Net Inc | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Net Income towards Common StockholdersNet Income | -4.07M | -3.73M | -4.28M | -4.46M | -2.26M | -3.73M | -4.15M | -5.07M | -3.28M | -4.61M | -5.53M | -5.22M | -4.99M | -5.74M | -4.62M | -4.54M | -4.25M | -4.13M | -3.36M | -3.48M | ||||||||
| Additional items | ||||||||||||||||||||||||||||
| EPS (Basic) | -0.36 | -0.34 | -0.39 | -0.41 | -0.21 | -0.34 | -0.38 | -0.47 | -0.30 | -0.43 | -0.51 | -0.49 | -0.46 | -0.53 | -0.43 | -0.42 | -0.39 | -0.38 | -0.30 | -0.28 | ||||||||
| EPS (Diluted) | -0.41 | -0.21 | -0.34 | -0.38 | -0.47 | -0.30 | -0.43 | -0.51 | -0.49 | -0.46 | -0.53 | -0.43 | -0.42 | -0.39 | -0.38 | -0.30 | -0.28 | |||||||||||
| Shares Outstanding | 11.19M | 10.90M | 10.88M | 10.83M | 10.84M | 10.85M | 10.86M | 10.86M | 10.86M | 10.84M | 10.74M | 10.76M | 10.76M | 10.76M | 10.78M | 10.78M | 10.83M | 10.90M | 11.25M | 12.42M | ||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 10.83M | 10.84M | 10.85M | 10.86M | 10.86M | 10.86M | 10.84M | 10.74M | 10.76M | 10.76M | 10.76M | 10.78M | 10.78M | 10.83M | 10.90M | 11.25M | 12.42M | |||||||||||
| EBITDA | -4.15M | -3.51M | -4.07M | -4.39M | -2.15M | -3.83M | -4.29M | -5.19M | -3.52M | -4.88M | -5.73M | -5.41M | -5.18M | -5.90M | -4.77M | -4.65M | -4.35M | -4.20M | -3.41M | -3.51M |